Home › Hodgkin Lymphoma › California
Hodgkin Lymphoma clinical trials in California
16 studies for Hodgkin Lymphoma are looking for participants at sites in California.
Cities in California
- Baldwin Park9 studies
- Mountain View6 studies
- Los Angeles3 studies
- Sacramento3 studies
- San Francisco3 studies
- Orange3 studies
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
- City of Hope Comprehensive Cancer Center, Duarte
- University of California Davis Comprehensive Cancer Center, Sacramento
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT05272384Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Stanford University Medical Center, Palo Alto
RecruitingObservational study
Ages 8 and older · All sexes · Updated Nov 10, 2026 · NCT06098430Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- City of Hope Cancer Center, Duarte
- Stanford University Medical Center, Stanford
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT03618550A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Stanford Cancer Institute, Palo Alto
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06150664CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- City of Hope Medical Center, Duarte
RecruitingPhase 2Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT06059391A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- City of Hope Medical Center, Duarte
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT07020533ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
- University of California Davis, Davis
- University of California San Francisco-Fresno, Fresno
- University of California Irvine, Irvine
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07021989AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Research Site, Duarte
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 13, 2026 · NCT06137144Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- City of Hope, Duarte
RecruitingPhase 1
Ages 18 to 100 · All sexes · Updated Sep 15, 2026 · NCT05798897Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06580002Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Stanford University - (Stanford Cancer Institute), Stanford
RecruitingPhase 3
Ages 16 to 69 · All sexes · Updated Jul 8, 2026 · NCT04685616A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- City of Hope, Duarte
- Children's Hospital of Los Angeles, Glendale
- Scripps Green Hospital, La Jolla
- and 8 more
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
- City of Hope National Medical Center, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06915246Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
- Stanford University School of Medicine, Stanford
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 24, 2025 · NCT00398177Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- City of Hope Medical Center, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT04871607Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital Orange County, Orange
- UCSF School of Medicine, San Francisco
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.